To reach the next value inflection
LicenseRx asset brief
A Mouse Model of Multiple Endocrine Neoplasia, Type I
Probability of Success
23% · grade C · Medium data confidence
Model PoS 23% (grade C, medium data confidence). Strongest signals: Data maturity, Indication pull. Biggest drag: Competitive whitespace.
Data maturity (22%)
59
Preclinical; human data.
IP position (16%)
45
No clear patent status in public data -- treat IP as unpriced until counsel confirms.
Modality feasibility (14%)
65
Modality unclear from public data -- assumed average development risk.
Indication pull (14%)
76
Oncology, Infectious Disease -- active buyer appetite.
Competitive whitespace (12%)
60
Crowded oncology field.
Translational evidence (12%)
70
Public evidence mentions: human, mouse, murine.
Licensing readiness (10%)
94
Listed as available for licensing; established tech-transfer office; 1 public source link(s).
Unlock the full strategic deep dive
Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.
View Operator access See what's included →